Prospective Registry of the Current Status of Care for Patients With Coronary Artery Disease
Launched by BEIJING ANZHEN HOSPITAL · Apr 13, 2022
Trial Information
Current as of April 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to understand how patients with coronary artery disease (CAD) are currently being cared for. Coronary artery disease is a condition where the blood vessels that supply the heart become narrow or blocked, which can lead to serious heart problems. The study is looking for hospitalized patients who have been diagnosed with CAD, whether it’s caused by the build-up of fatty deposits (atherosclerosis) or other factors.
If you or a family member is between the ages of 65 and 74 and has recently been hospitalized with a diagnosis of coronary artery disease, you may be eligible to participate in this study. There are no exclusions based on other health conditions, so many patients can join. Participants will help researchers gather important information about the current care practices for CAD, and by doing so, they may contribute to improving treatment for future patients. This is an ongoing study, and it aims to include a diverse group of participants to get a clearer picture of CAD care today.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hospitalized patients with discharge diagnosis as coronary artery disease (including atherosclerosis or non-athrosclerosis)
- Exclusion Criteria:
- • None
About Beijing Anzhen Hospital
Beijing Anzhen Hospital is a leading medical institution in China, renowned for its expertise in cardiovascular diseases and comprehensive healthcare services. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation, facilitating the development of new therapies and treatment protocols. With a focus on patient safety and ethical standards, Beijing Anzhen Hospital collaborates with various research entities to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing the understanding of cardiovascular health. Its commitment to excellence in clinical research is underscored by a multidisciplinary team of experienced healthcare professionals and a state-of-the-art facility equipped to support a wide range of clinical investigations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Beijing, , China
Patients applied
Trial Officials
Shaoping Nie, MD, PhD
Principal Investigator
Beijing Anzhen Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials